Protective properties of spliced X box binding protein 1 in ozone‑induced spinal cord neuronal death

  • Authors:
    • Yun Li
    • Xu Zhao
    • Xiaowen Lin
    • Xuejun Zhao
    • Juntian Xie
    • Tao Sun
    • Zhijian Fu
  • View Affiliations

  • Published online on: June 22, 2018     https://doi.org/10.3892/mmr.2018.9212
  • Pages: 2349-2355
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Administration of ozone (O3) is often used in the treatment of low back pain. Administration of O3 can, however, cause neurotoxicity in spinal cord neurons via induction of endoplasmic reticulum (ER) calcium (Ca2+) release and activation of the Ca2+/calmodulin‑dependent protein kinase II (CaMKII)/mitogen‑activated protein kinase (MAPK) pathway. The aim of the current study was to confirm whether administration of O3 causes ER stress and if the consequential overexpression of adenovirus‑mediated spliced X box binding protein 1 (XBP1s), which is the effector of ER stress and a crucial transcriptional factor gene in charge of cell survival, has a protective effect on spinal cord neurons after O3 exposure. To address this aim, the expression of GRP78, an ER chaperone and signaling regulator, and the expression of XBP1s in rat primary spinal cord neurons that underwent O3 exposure were investigated. Primary neurons exposed to O3 exhibited increased GRP78 and XBP1s expression levels. Interestingly, the effect of decreased neuron viability was blocked when cells were pretreated with Adv‑XBP1s. Moreover, overexpression of XBP1s suppressed cell death caused by O3 exposure. These results suggest that overexpression of activated XBP1s protects against neuronal cell death following O3 exposure and that activation of the XBP1s pathway may offer a preventative way for prophylactic treatment of spinal cord neurons exposed to O3.

Introduction

Ozone (O3) is a strong oxidizing agent and has been widely used in the treatment of protrusion of lumbar intervertebral disc (PLID), failed back surgery syndrome (FBSS), soft tissue lesions and arthralgia (13). However, Ginanneschi et al have reported ventral and dorsal root injury after intervertebral disc infiltration of O2O3 on L4-L5 disc herniation. Thus, physicians must distinctly comprehend the risk of potential complications (4). Therefore, whether O3 has neurotoxicity in spinal cord neurons (SCNs) has led to increasing attention to the clinical applications of O3. Previous study results suggest that exposure to O3 may cause SCNs death and that the neurotoxicity caused by O3 is related to the increasing calcium (Ca2+) release from endoplasmic reticulum (ER), thus enhancing the activity of the Ca2+/calmodulin-dependent protein kinase II (CaMKII)/mitogen-activated protein kinase (MAPK) pathway (5).

The ER is a multifunctional organelle that manages and participates in a wide range of cellular processes, which include protein synthesis and protein folding, handling of misfolded proteins and posttranslational modification, and delivery of proteins to their eventual destination (6). The ER forms an interconnected network of flattened, membrane-enclosed sacs in cytoplasm. It is an organelle that can provide a place to synthesize proteins and lipids. During ER stress, the intracellular folding protein and (or) unfolded protein accumulates in the ER. The cell reacts to obliterate these defective proteins, which is a process called unfolded protein response (UPR) (7). Oxidative stress damage and Ca2+ depletion, which are induced by a series of toxic insults, bring about the accumulation of unfolded or misfolded proteins in the ER and lead to the dysfunction of the UPR, resulting in the onset of ER stress and cell death (8). In mammalian cells, several ER-residing transmembrane proteins have been identified as transducers of the ER stress signaling pathway, namely: Inositol-requiring ER-to-nucleus signal kinase 1 (IRE1), PKR-like ER kinase (PERK) and activating transcription factor 6 (ATF6) (9). Following activation of UPR, these transducers of ER stress are dimerized or cleaved to reduce the UPR response. In particular, dimerization and phosphorylation of IRE1 with RNase activity promotes the splicing of X box binding protein-1 (XBP1s) mRNA in mammalian cells. ER stress activates the RNase activity of IRE1α, leading to removal of 26 nucleotides from XBP1s transcripts by unorthodox RNA splicing, which transforms the inactive form of XBP1mRNA (XBP1u) into an active form (XBP1s) (10). In addition, it has been reported that processed XBP1 mRNA is rendered into the 54 kDa processed XBP1s (11). XBP1s is a basic leucine zipper (bZIP)-containing transcription factor, which was initially recognized as a protein attaching to the cis-acting X box region in the promoter region of the human major histocompatibility complex class II genes. It is indispensable for immunoglobulin secretion and the development of plasma cells in mammals. The expression of GRP78 is induced by XBP1s through a promoter which contains the ER response element (ERSE). Accordingly, ER stress results in dimerization of PERK, resulting in the activation of PERK, thereby inducing phosphorylation of eIF2α, the general attenuation of protein translation, and increased translation of the transcriptional factor ATF4 protein (12). The increasing translation of ATF4 can regulate the expression of C/EBP homologous protein (CHOP), which is the downstream gene of ATF4. Both GRP78 and CHOP, which are sentinel markers for ER stress under pathologic conditions, bind to newly synthesized proteins transiently and are then translocated into the ER along with permanent unfolded or misfolded proteins (13).

It has been reported that XBP1s are effective transcription factors with diverse targets specific for the expression of ER chaperones and ER-associated degradation (ERAD) components, both of which are crucial to discharge the ER burden (14). However, ER stress may play an essential role in neuronal apoptosis, and the role of XBP1s in O3-induced ER stress remains unknown (15). The current study investigated whether exposure to low concentrations of O3 induced increased expression of GRP78 and XBP1s, and whether activation of XBP1s is neuroprotective against O3-induced ER stress.

Materials and methods

Animals and reagents

All programs involving the use of animals were conducted in adherence to the guidelines of the National Institutes of Health (NIH; Bethesda, MD, USA) and were approved by the Animal Care and Use Committee of the School of Medicine of Shandong University (Shandong, China). Neurobasal medium and B27 supplement were purchased from Gibco; Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Trypsin, phenylmethylsulfonyl fluoride (PMSF) and bovine serum albumin (BSA) were obtained from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). The following primary antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA): XBP1s, CHOP and GRP78. Anti-β-actin antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

Construction of recombinant adenovirus

The complementary DNAs encoding the full-length Rat XBP1s proteins were amplified from isolated ovary total RNA by reverse transcriptase polymerase chain reaction (RT-PCR). To clone the full-length XBP1s cDNA (GenBank acc. no. NM_005080), the following primers were used: Forward, 5′-TGAAGCTTTGCGTAGTCTGGAGCTATGG-3′ and reverse, 5′-TGCTCGAGATTGGATCATTCCTTAGACA-3′. The coding reading frame of the cloned XBP1s gene was identified by sequencing and subcloned into shuttle plasmid pShuttle-CMV (Agilent, US). The constructed recombinant shuttle plasmid pShuttle-CMV-XBP1s was digested with I-CeuI and I-SceI, and the obtained expression frame of the XBP1s gene was linked to the vector carrying the pAdEasy adenovirus backbone. The recombinant adenovirus backbone was linearized by digestion with PacI and infected into HEK 293 cells for packing to obtain recombinant adenovirus Adv-XBP1s. The adenovirus was purified from the HEK 293 cell extracts by cesium chloride (CsCl; Nacalai Tesque, Kyoto, Japan) density ultracentrifugation according to the company manual (Takara Bio, Inc., Otsu, Japan). Viral stocks were stored in 10% glycerol at −80°C and diluted with phosphate buffered saline (PBS) to the appropriate concentration prior to use. Ad-GFP, which encodes enhanced green fluorescent protein (Clontech, Palo Alto, CA), was constructed similarly by overlap recombination. The Adv-LacZ was made by the same procedure.

Primary spinal cord neuronal cultures

Primary SCNs cultures were prepared from 30 Wistar rats (1–2-days-old), as previously described (16) with minor modifications. The rats were kept by breastfeeding during a 12-h dark/light diurnal cycle. Briefly, the spinal cord from newborn rats within 48 h was digested for 30 min with trypsin (0.125%; Sigma-Aldrich; Merck KGaA). 10% fetal calf serum (FCS) was added to stop digestion and passed through a 100-eye sieve. The cell suspension was centrifuged at 1,000 rpm for 8 min. Then, cells were washed three times with a basic culture medium with 2 mmol/l L-glutamine, penicillin (100,000 U/l), streptomycin (100 mg/l) and 10% FCS. Cells were resuspended in fresh Neurobasal medium with 2 mmol/l L-glutamine, 2% (v/v) B27 supplement, penicillin (100,000 U/l) and streptomycin (100 mg/l). Cells were seeded on poly-L-lysine (0.1 g/l)-coated dishes at a density of 0.125×106 cells/cm2 for the cell counting kit-8 (CCK-8) assay or 0.33×106 cells/cm2 for protein extraction for western blot or 0.25×106 cells/cm2 for total RNA extraction for reverse transcription-quantitative polymerase chain reaction (RT-qPCR). For fluorescence experiments, neurons were mounted on poly-L-lysine-coated glass coverslips at a density of 0.1×106 cells/cm2 or on poly-L-lysine-coated dishes at 0.4×106 cells/cm2. After 24 h, cells were treated with 0.1 mg/ml of cytosine arabinoside (Sigma-Aldrich; Merck KGaA) to suppress glia proliferation. Fresh growth medium was applied 2 times a week. Under these conditions, glia growth was <10%.

Microtubular associated protein 2 (MAP2) is specifically expressed in the neuron. We identified neurons by a positive expression of MAP2 by immunofluorescence. The cells were identified after culturing for 7 days. Briefly, cells were washed with PBS three times and fixed with 4% paraformaldehyde for 15 min. Then, 0.2% TritonX-100 was used for cell permeabilization for 5 min, after which cells were blocked with goat serum at room temperature for 1 h and incubated with anti-MAP2 monoclonal (cat. no. ab32454; 1:2,000; Abcam, Cambridge, UK) overnight at 4°C. The next day, cells were incubated with secondary antibody (cat. no. ab150077; 1:400; Abcam) for 1 h in a dark room. Stained neurons were visualized using immunofluorescence microscopy.

Adenovirus transduction

Before being exposed to adenoviral vectors, the primary SCNs were maintained for two days. Culture medium was added to dilute high titer adenovirus to accomplish a multiplicity of infection (MOI) of 20–400 plaque forming units (pfu)/cell. 100 ml of culture medium was removed and replaced with 50 ml of culture medium with adenovirus preparation for transduction. 50 ml of medium was added to the culture after 2 h. Incubation with adenovirus continued for 16 h. Then, the adenovirus medium was removed and cells were cultured in fresh culture medium. Primary SCNs were treated with adenovirus one day after plating. Cells were incubated with adenovirus at an MOI of 0–500 for 2 h. Then, the adenovirus-containing medium was replaced with fresh medium after 2 h.

O3 exposure

The O3 concentration was obtained through the pre-experiment. CCK-8 assay result showed that the medical O3 of 40 µg/ml can reduce neuronal cell viability significantly (5). Cells were exposed to 40 µg/ml O3 or tunicamycin (2 µg/ml) for 60 min. SCNs exposure to O3 at specified levels were carried out in an O3 exposure chamber in vitro, which was controlled by a computer (17). The SCNs stored a thin layer of medium apically and were exposed to O3. Cells were rocked to expose one side of the apical surface at the time to O3 exposure. O3 concentration in the chamber was detected accurately by an O3 analyzer (Model MD-050-12-f-4; Perma Pure Inc., Toms River, NJ, USA) and adjusted by a computerized system.

Isolation of RNA and RT-qPCR

Total RNA was prepared by TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions and was reverse transcribed to cDNA using the MML-V reverse transcriptase kit (Takara Bio, Inc.). The expression of XBP1s mRNA was examined by qPCR on a 7500-real time RT-PCR system and software (Prism 7500; Applied Biosystems Inc., Foster City, CA, USA) using a Realtime PCR Master Mix kit (Thermo Fisher Scientific, Inc., Pittsburgh, PA, USA). qPCR was performed under the following conditions: 95°C for 30 sec followed by 40 cycles of 95°C for 5 sec and 60°C for 34 sec. GAPDH was used as an internal standard. The Prime sequences are shown as follows, GAPDH forward, 5′-CCCCCAATGTATCCGTTGTG-3′ and reverse, 5′-TAGCCCAGGATGCCCTTTAGT-3′; XBP1s forward, 5′-TGAAGCTTTGCGTAGTCTGGAGCTATGG-3′ and reverse, 5′-TGCTCGAGATTGGATCATTCCTTAGACA-3′. Samples were determined in triplicate.

Western blot analysis

Cells were collected after transfection for 24 h. Total protein was prepared according to the manufacturer's directions. Briefly, rat SCNs were lysed in RIPA buffer with protease inhibitors (in mmol/l: Leupeptin, 0.1 and PMSF, 0.3), and stored on ice for 30 min and vortexed every 5 min. The supernatant was collected after centrifugation at 14,000 rpm for 30 min at 4°C. The protein concentration was detected by a Bio-Rad DC protein assay kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). A total of 50 µg protein was loaded in each lane of standard 4–12% SDS-polyacrylamide gels to ensure loading consistency, as previously described. Following electrophoresis and transfer of proteins to nitrocellulose membranes, the membranes were blocked in PBS containing 0.1% Tween (TBST) and 5% non-fat milk for 1 h. Membranes were incubated in primary anti-GRP78 (ab108613; 1:1,000), anti-CHOP (CST; cat. no. 2895; 1:1,000) and anti-XBP1s (cat. no. ab37152; 1:1,000; all Abcam) antibody overnight at 4°C. The membranes were incubated with horseradish peroxidase-labeled goat anti-rabbit IgG (Thermo Fisher Scientific, Inc.) as a secondary antibody (1:2,000) at room temperature for 1 h and then developed using ECL (GE Healthcare, Chicago, IL, USA) for detection. The bands densities were quantified by Image J image software v2.1.4.7 (NIH).

Evaluation of neuronal injury

Before exposure to O3 with the presence or absence of 24 h Adv-XBP1s pretreatment, cells in 96-well plates (2×104 cells/well) were washed with fresh medium and were cultured. Then, fresh medium was used to incubate the cells. Finally, the CCK-8 solution (10 µl) (Dojindo Laboratories, Kumamoto, Japan) was added to each well for 2 h at 37°C. Samples were measured by optical absorbance at 450 nm using an absorbance microplate reader (ELx800 Absorbance Microplate Reader; Bio-Tek, USA).

Statistical analysis

Data are presented as the mean ± standard deviation (SD). The results were analyzed using one-way analysis of variance (ANOVA), followed by the Student-Newman-Keuls test for multiple comparisons with SPSS v13.0 Software (SPSS Inc., Chicago, IL, USA). A P-value of P≤0.05 was considered statistically significant.

Results

Adenovirus mediated gene transfer into the primary SCNs

Adenovirus transduction efficiency was first optimized in the cultures. The primary SCNs were transduced with different adenovirus MOI (5, 10, 50, 100, 150, 200, or 500) and with varying adenovirus incubation times (2, 8, 18, 24 or 36 h) (Fig. 1). We found the best transduction efficiency was when the primary cultures were transfected with adenovirus two days after planting and incubation for 24 h. Under the above conditions, 83% XBP1s-positive cells could be seen in the primary SCNs three days after transduction with an MOI of 100 pfu/cell (Fig. 1A and B). Cytotoxic effects began to appear as MOI of 500 pfu/ cell.

Adenovirus mediated overexpression of XBP1s in primary SCNs

To examine in vitro XBP1s expression levels following Ad vector infection, Western blotting and quantitative Real-time-PCR analysis were performed. We observed an apparent increase in the XBP1s expression after transduction with Adv-XBP1s in primary SCNs (Fig. 2). The control Ad vector Ad-LacZ did not increase XBP1s expression, indicating that transduction with Ad vectors alone does not induce any change in the cell systems.

O3 exposure induced the ER stress response and XBP1splicing

ER stress, which is internally linked to cell apoptosis, is one of the primary cell stress responses. Therefore, neurons are hypersensitive to ER stress challenge, and the current study investigated whether O3 (40 µg/ml O3 for 60 min) activated the ER stress response and expression of GRP78 and CHOP, which are involved in ER stress in SCNs. As shown in Fig. 3A and B, the ER stress response of SCNs exposed to O3 was evidenced by an increase in GRP78 and CHOP protein levels. These results show that O3 (40 µg/ml O3 for 60 min) activates the ER stress response.

Treatment of SCNs with O3 (40 µg/ml O3 for 60 min) also increased the expression of XBP1s, as detected by a specific antibody (Fig. 3C). Analysis of XBP1 mRNA revealed O3 induced splicing of XBP1 mRNA. The splicing of XBP1 mRNA caused by O3 in SCNs was the same as that induced by the classical ER stress inducer Tunicamycin (Fig. 3D). These results indicate that O3 exposure increased XBP1s expression in SCNs.

Adenovirus-mediated XBP1s overexpression prevent ER stress and protects O3-induced cell death in rat primary SCNs

During UPR, XBP1s regulate the expression of many ER stress factors that include ER chaperones and ERAD components that repair normal ER physiology. Thus, we conjecture whether XBP1s overexpression could revert the ER stress induced by O3. To detect ER stress independently of XBP1, we examined the activity of GRP78 and CHOP. Before exposure to O3, both GRP78 and CHOP expression was maintained at a lower level. However, after exposure to O3, GRP78 and CHOP expression was significantly higher (Fig. 4A and B). This suggests that overexpression of XBP1s may play a neuroprotective role in ER stress.

To investigate the effect of Adv-XBP1s on O3-induced SCNs injury, SCNs were pretreated with 100MOI Adv-XBP1s for 24 h, followed by 40 µg/ml O3 treatment for 1 h. As shown in Fig. 4, O3-induced loss of cell viability was significantly reversed by the overexpression of XBP1s. These results indicate that Adv-XBP1s have a protective effect against O3-induced toxicity in SCNs.

Discussion

Previously, O3 treatment has been widely applied in the treatment of PLID, FBSS, soft tissue lesions and arthralgia (18). The effect of O3 on the CNS, particularly biological mechanisms, has been confirmed in a previous study conducted in the authors' laboratory (5). The focus of the present study was to investigate whether there is a novel and effective method to prevent neurotoxicity induced by O3. In the present study, SCNs were exposed to O3 to induce GRP78 and XBP1 activation, resulting in increased cell death. Interestingly, pretreatment of cells with Adv-XBP1s inhibited these effects. The aim of the current study was to provide insight into the protective role of XBP1s overexpression. To address this aim, the role of XBP1s, a critical UPR effector, was investigated using an in vitro rat primary SCNs model of O3 injury.

This study focuses on the protective role of XBP1s in O3-induced spinal cord neuronal death. First, ER stress was activated during O3-induced SCNs death. As a result, an increase in GRP78 and CHOP levels as well as extensive splicing of XBP1s appeared upon O3 treatment (Fig. 3A-C). Second, SCNs with XBP1s overexpression prevented cell death, and partially reduced the protein levels of GRP78 and CHOP (Fig. 4A and B). Strong activation of GRP78 was also observed in previous studies during tunicamycin (an inhibitor of N-linked glycosylation) and thapsigargin (an inhibitor of the ER Ca2+-ATPase) treatment. In our study, we observed a similar result where the transcription and protein expression levels of XBP1s in SCNs were significantly increased after tunicamycin treatment (Fig. 3C and D). As a sentinel marker for ER stress under pathologic conditions, GRP78 binds transiently to newly synthesized proteins translocated into the ER and more permanently to unfolded or misfolded proteins (19). GRP78 can trigger the UPR via dissociation from its interaction partners PERK, ATF6 and IRE1a, which can subsequently lead to activation of ER stress responses involving an induced expression of ER chaperones to increase the folding capacity of the ER. When ER stress occurs, sensor proteins from the ER membrane are dimerized or cleaved to weaken this condition. IRE1, which is a sensor protein with RNase activity, is dimerized and phosphorylated to expedite splicing of mRNA for XBP1 in mammalian cells (14,20). XBP1s protein from spliced mRNA induces GRP78 expression via a promoter containing the ERSE.

In addition, CHOP is a transcription factor belonging to the (c/EBP) family that induces cell cycle arrest and apoptosis in ER stress and DNA damage response (21). Basal expression of CHOP is very low under non-stressed conditions; however, its expression is induced by a number of adverse physiological conditions. The expression of CHOP is both cell- and stimulus-dependent, and thus has an influence on the final result of ER stress. The expression of CHOP is strongly induced via IRE1 and PERK signaling (22). Our research showed that SCNs exposed to O3 had clearly raised the expression levels of CHOP, which is an ER-related chaperone (Fig. 3A and B). This suggested that O3 (40 µg/ml) might induce SCNs death through ER stress and DNA damage.

In the UPR, the expressions of ER chaperones and ERAD-related genes appear to be largely regulated by the IRE1α-XBP1s pathway (20,23). The activated form of XBP1s upregulates many ER chaperones and genes involved in ERAD, various UPR ‘stress genes’, and enzymes involved in membrane biogenesis (24). In addition, the overexpression of XBP1s plays a protective role in a neuroblastoma cell line against cell death, which is induced by proteasome inhibition (25). XBP1s overexpression protected against oxygen and glucose deprivation/reoxygenation injury in rat primary hippocampal neurons (26). This is meet with our research. Besides, a recent study showed that overexpression of XBP1s can promote proliferation in bone marrow-derived macrophages (27), which is in accordance with our results. Our research work found that overexpression of XBP1s protected SCNs from O3-induced cell death, which may play a protective role through the IRE1α-XBP1 pathway. Whether the protective role of overexpression of XBP1s is involved in some ER-related genes or enzymes will be investigated in future research.

Taken together, it was hypothesized that the activation of the XBP1s pathway and its downstream ER chaperones could prevent cytotoxicity and play a protective effect. Therefore, the impact on the activation of the IRE1α-XBP1s pathway in opposition to cell death induced by these damages in addition to representative ER stressors were investigated. As expected, pretreatment with adenovirus-mediated overexpression of XBP1s strongly reduced SCNs death induced by O3.

These results suggest that XBP1s activation could potentially be applied to prevent ER stress-related neurotoxicity and this cytoprotective effect was confirmed by XBP1s overexpression. Furthermore, XBP1s and other components of the ER stress response pathway could serve as potential drug targets in preventative strategies for neurotoxicity associated with ER stress. While the current study provides in vitro data regarding the protective role of overexpression of XBP1 in SCNs, in vivo therapeutic implications are still required.

Acknowledgements

The authors would like to thank the Central Laboratory affiliated Shandong Provincial Hospital (Jinan, China).

Funding

The present study was funded by grants from the National Natural Science Foundation of China (grant no. 81271346) and the Natural Science Foundation of Shandong Province, China (grant no. ZR2010HM097).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

ZF, XL and YL conceived and designed the experiments. YL and XZ performed the experiments. XJZ, JX and TS conducted data analysis. YL and XZ produced the manuscript.

Ethics approval and consent to participate

All animal experiments were approved by Animal Care and Use Committee of Shandong Provincial Hospital Affiliated to Shandong University.

Patient consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests.

References

1 

Elvis AM and Ekta JS: Ozone therapy: A clinical review. J Nat Sci Biol Med. 2:66–70. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Paoloni M, Di Sante L, Cacchio A, Apuzzo D, Marotta S, Razzano M, Franzini M and Santilli V: Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: A multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976). 34:1337–1344. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Zhang Y, Ma Y, Jiang J, Ding T and Wang J: Treatment of the lumbar disc herniation with intradiscal and intraforaminal injection of oxygen-ozone. J Back Musculoskelet Rehabil. 26:317–322. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Ginanneschi F, Cervelli C, Milani P and Rossi A: Ventral and dorsal root injury after oxygen-ozone therapy for lumbar disk herniation. Surg Neurol. 66:619–621. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Li Y, Lin X, Zhao X, Xie J, JunNan W, Sun T and Fu Z: Ozone (O3) elicits neurotoxicity in spinal cord neurons (SCNs) by inducing ER Ca(2+) release and activating the CaMKII/MAPK signaling pathway. Toxicol Appl Pharmacol. 280:493–501. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Hetz C: The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 13:89–102. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Verkhratsky A and Petersen OH: The endoplasmic reticulum as an integrating signalling organelle: From neuronal signalling to neuronal death. Eur J Pharmacol. 447:141–154. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Tang CH, Chiu YC, Huang CF, Chen YW and Chen PC: Arsenic induces cell apoptosis in cultured osteoblasts through endoplasmic reticulum stress. Toxicol Appl Pharmacol. 241:173–181. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Zhang K and Kaufman RJ: Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem. 279:25935–25938. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM and Walter P: IRE1 signaling affects cell fate during the unfolded protein response. Science. 318:944–949. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Paschen W, Aufenberg C, Hotop S and Mengesdorf T: Transient cerebral ischemia activates processing of xbp1 messenger RNA indicative of endoplasmic reticulum stress. J Cereb Blood Flow Metab. 23:449–461. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Lu PD, Harding HP and Ron D: Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol. 167:27–33. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Yoshida H, Yanagi H, Yura T and Mori K: Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulate proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem. 273:33741–33749. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Yoshida H: Unconventional splicing of XBP-1 mRNA in the unfolded protein response. Antioxid Redox Signal. 9:2323–33. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Chen J, Qin J, Liu X, Han Y, Yang Z, Chang X and Ji X: Nitric oxide-mediated neuronal apoptosis in rats with recurrent febrile seizures through endoplasmic reticulum stress pathway. Neurosci Lett. 443:134–139. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Marsala M, Kakinohana O, Hefferan MP, Cizkova D, Kinjoh K and Marsala S: Synaptogenesis and amino acid release from long term embryonic rat spinal cord neuronal culture using tissue culture inserts. J Neurosci Methods. 141:21–27. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Ahmad A, Ahmad S, Chang LY, Schaack J and White CW: Endothelial Akt activation by hyperoxia: Role in cell survival. Free Radic Biol Med. 40:1108–1118. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Muto M, Ambrosanio G, Guarnieri G, Capobianco E, Piccolo G, Annunziata G and Rotondo A: Low back pain and sciatica: Treatment with intradiscal-intraforaminal O (2)-O (3) injection. Our experience. Radiol Med. 113:695–706. 2008.(In English, Italian). View Article : Google Scholar : PubMed/NCBI

19 

Yoshida H, Matsui T, Yamamoto A, Okada T and Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 107:881–891. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Lee AE, Iwakoshi NN and Glimcher LH: XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 23:7448–7459. 2003. View Article : Google Scholar : PubMed/NCBI

21 

Oyadomari S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Mihailidou C, Papazian I, Papavassiliou AG and Kiaris H: CHOP-dependent regulation of p21/waf1 during ER stress. Cell Physiol Biochem. 25:761–766. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Yamauchi T, Sakurai M, Abe K, Matsumiya G and Sawa Y: Impact of the endoplasmic reticulum stress response in spinal cord after transient ischemia. Brain Res. 1169:24–33. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Ron D and Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 8:519–529. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T, et al: Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res. 1257:16–24. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Ibuki T, Yamasaki Y, Mizuguchi H and Sokabe M: Protective effects of XBP1 against oxygen and glucose deprivation/reoxygenation injury in rat primary hippocampal neurons. Neurosci Lett. 518:45–48. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Tian PG, Jiang ZX, Li JH, Zhou Z and Zhang QH: Spliced XBP1 promotes macrophage survival and autophagy by interacting with Beclin-1. Biochem Biophys Res Commun. 463:518–523. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2018
Volume 18 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Zhao X, Lin X, Zhao X, Xie J, Sun T and Fu Z: Protective properties of spliced X box binding protein 1 in ozone‑induced spinal cord neuronal death. Mol Med Rep 18: 2349-2355, 2018
APA
Li, Y., Zhao, X., Lin, X., Zhao, X., Xie, J., Sun, T., & Fu, Z. (2018). Protective properties of spliced X box binding protein 1 in ozone‑induced spinal cord neuronal death. Molecular Medicine Reports, 18, 2349-2355. https://doi.org/10.3892/mmr.2018.9212
MLA
Li, Y., Zhao, X., Lin, X., Zhao, X., Xie, J., Sun, T., Fu, Z."Protective properties of spliced X box binding protein 1 in ozone‑induced spinal cord neuronal death". Molecular Medicine Reports 18.2 (2018): 2349-2355.
Chicago
Li, Y., Zhao, X., Lin, X., Zhao, X., Xie, J., Sun, T., Fu, Z."Protective properties of spliced X box binding protein 1 in ozone‑induced spinal cord neuronal death". Molecular Medicine Reports 18, no. 2 (2018): 2349-2355. https://doi.org/10.3892/mmr.2018.9212